BPC-157 Stable vs TB-500

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

BPC-157 Stable is primarily a healing & recovery peptide, while TB-500 is used for bone & joint.

This page compares BPC-157 Stable and TB-500 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

BPC-157 StableTB-500
CategoryHealing & RecoveryBone & Joint
Regulatory status (US)Compounding (Rx) — Apr 2026Compounding (Rx) — Apr 2026
Typical dosage250-500 mcg2-5 mg
Frequencydailyweekly
Reported benefitsSame as BPC-157 with enhanced stabilityBone healing, joint mobility, connective tissue support
Reported side effectsMinimal, same as regular BPC-157Well-tolerated

Key differences

Primary use. BPC-157 Stable is categorised under Healing & Recovery, while TB-500 falls under Bone & Joint. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. BPC-157 Stable: not FDA-approved; compounding permitted with a prescription as of April 2026. TB-500: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. BPC-157 Stable is typically dosed at 250-500 mcg (daily). TB-500 is typically dosed at 2-5 mg (weekly).

Can you stack them?

Some protocols combine peptides, but stacking BPC-157 Stable and TB-500 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between BPC-157 Stable and TB-500?
BPC-157 Stable is primarily a healing & recovery peptide, while TB-500 is used for bone & joint. BPC-157 Stable is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).
What is BPC-157 Stable used for?
Stabilized BPC variant.
What is TB-500 used for?
Connective tissue repair.
Can you take BPC-157 Stable and TB-500 together?
Some users combine peptides within a single protocol, but stacking BPC-157 Stable and TB-500 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is BPC-157 Stable or TB-500 FDA-approved?
BPC-157 Stable is not FDA-approved; compounding permitted with a prescription (as of April 2026). TB-500 is not FDA-approved; compounding permitted with a prescription (as of April 2026).

Read the full articles

  • BPC-157 Stable — full monograph: mechanism, research, dosing & references
  • TB-500 — full monograph: mechanism, research, dosing & references

More Healing & Recovery comparisons

← All peptide comparisons